Status:
COMPLETED
2nd_Computerized Asthma Specific Quality of Life(cAQOL)
Lead Sponsor:
Ajou University School of Medicine
Collaborating Sponsors:
Yonsei University
Inha University Hospital
Conditions:
Persistent Asthma Patient
Eligibility:
All Genders
20-70 years
Brief Summary
Comparison of the responsiveness of two different asthma-specific QOL measures (AQLQ and cAQOL) in Korean patients with persistent asthma
Eligibility Criteria
Inclusion
- Patient aged 20-70 years
- Patient diagnosed with asthma over six months ago
- Asthma diagnosis
- Airway reversibility, FEV1 ≥ 12% and 200mL or
- Airway hyper-responsiveness, PC20 \< 16 mg/mL or
- More than two weeks, more than 2 times a day in excess of 20% PEFR diurnal variability patient
- FEV1 55-100% of predicted value patient
- Inhaled corticosteroids alone or inhaled corticosteroids and beta agonists used patient
- Currently, at least if you have one or more asthma symptoms, asthma control test (ACT • Asthma Control Test) score of less than 19 characters
- Patients who sufficiently listen to the purpose and content of this trial and the properties of investigational products and voluntarily agree with the participation to sign a written consent approved by IRB of Ajou University Medical Center before the participation in this trial
Exclusion
- Current smoking or smoking in the past 15packyears
- Patients who show a symptom of an acute disease within 14 days before the beginning of this trial (administration of trial medication)
- Recent changes in asthma treatment for 28days
- Chronic diseases that affect the quality of life
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01227083
Start Date
October 1 2010
End Date
July 1 2012
Last Update
November 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Medical Center
Suwon, South Korea, 443-721